2024-11-11T11:48:16-06:00 2023-12-31 420704554 BROWN WINICK GRAVES GROSS & BASKERVILLE 666 GRAND AVENUE SUITE 2000 DES MOINES IA 503092510 990 2023-01-01 473408746 SWINE HEALTH INFORMATION CENTER INC SWIN 7854528270 1310 WESTLOOP PLACE A 270 MANHATTAN KS 66502 DR MEGAN NIEDERWERDER EXECUTIVE DIRECTOR 7854528270 2024-11-08 1 0 CHRISTOPHER L NUSS P00964689 5152422400 2024-11-08 2023 2024-10-15 13:58:12Z X DR MEGAN NIEDERWERDER 1310 WESTLOOP PLACE A 270 MANHATTAN KS 66502 3159430 0 X WWW.SWINEHEALTH.ORG X 2015 IA PROTECT AND ENHANCE THE HEALTH OF THE U.S. SWINE HERD THROUGH COORDINATED GLOBAL RESEARCH MONITORING, TARGETED RESEARCH INVESTMENTS THAT MINIMIZE THE IMPACT OF FUTURE DISEASE THREATS, AND ANALYSIS OF SWINE HEALTH DATA. 9 9 2 75 0 0 4461762 2887030 0 0 -26943 272400 0 0 4434819 3159430 1276783 1946090 0 0 541537 669372 0 0 0 398363 284425 2216683 2899887 2218136 259543 6710364 6557768 1272263 1663245 5438101 4894523 X PROTECT AND ENHANCE THE HEALTH OF THE U.S. SWINE HERD THROUGH COORDINATED GLOBAL RESEARCH MONITORING, TARGETED RESEARCH INVESTMENTS THAT MINIMIZE THE IMPACT OF FUTURE DISEASE THREATS, AND ANALYSIS OF SWINE HEALTH DATA. 0 0 1344677 932329 MONITOR SWINE DISEASES AROUND THE WORLD TO IDENTIFY POTENTIAL RISKS TO THE US SWINE HERD. USE THAT INFORMATION TO INFORM SWINE HEALTH AND BIOSECURITY RESEARCH PRIORITIES FOR THE US PORK INDUSTRY, INCLUDING ALLIED INDUSTRIES, SO THAT APPROPRIATE MEASURES CAN BE IMPLEMENTED TO PREVENT INTRODUCTION INTO THE US. FILL GAPS OF RESEARCH AND INFORMATION NEEDED TO PREVENT, PREPARE AND RESPOND TO FOREIGN ANIMAL OR EMERGING DISEASES. INVESTIGATE THE ABILITY OF COMMON INPUTS THAT MIGHT QUICKLY INTRODUCE DISEASE INTO HERDS ACROSS THE COUNTRY, SUCH AS FEED, PESTS, SUPPLIES, AND OTHER FOMITES. RESEARCH FOCUSES ON OBTAINING DATA SUFFICIENT TO SUPPORT A COMPREHENSIVE RISK ASSESSMENT ABOUT POTENTIAL ROLES OF COMMON INPUTS AND THEIR MOVEMENTS IN DISEASE INTRODUCTION AND DISSEMINATION. RESEARCH AND COMMUNICATE COST-EFFECTIVE IMPROVEMENTS IN NATIONAL, REGIONAL AND ON-FARM BIOSECURITY TO PREVENT DISEASE INTRODUCTION. INTERACT WITH INTERNATIONAL ORGANIZATIONS AND ANIMAL HEALTH COMPANIES TO PROVIDE INPUT AND INFORMATION INTO GLOBAL DISEASE RISK AND MITIGATION. 672339 466165 MAKE INDUSTRY SWINE HEALTH INFORMATION AVAILABLE TO HELP IDENTIFY, COMMUNICATE, AND MITIGATE REGIONAL AND NATIONAL RISKS TO HERD HEALTH. SURVEY TO IDENTIFY PATHOGENS AND EMERGING DISEASES AND UNCOVER REGIONAL DIFFERENCES THAT MIGHT BE ABLE TO BE USED IN PREDICTING DISEASE RISK AND CURRENT OUTBREAK MODELS. REFINE DOMESTIC SWINE DISEASE MONITORING AND REPORTING. INFORM THE INDUSTRY ABOUT EMERGING DISEASES OR SYNDROMES THAT MIGHT LOOK LIKE AN ISOLATED INCIDENT TO HELP PRODUCERS EVALUATE AND PREPARE FOR HEALTH RISKS, SUPPORTING THE DEVELOPMENT OF AN EFFECTIVE DISEASE RISK AND OUTBREAK MODEL. DEVELOP THE INDUSTRY CAPACITY FOR DETECTION OF EMERGING DISEASES FOR RAPID RESPONSE AND BUSINESS CONTINUITY. 672339 466165 ENHANCE DETECTION OF EMERGING DISEASE TO FACILITATE RAPID RESPONSE. OFFER DIAGNOSTIC FEE SUPPORT TO HELP DETECT EMERGING DISEASES SO THEY ARE QUICKLY AND ACCURATELY IDENTIFIED FOR ACTION BY THE INDUSTRY. INVESTIGATE INNOVATIVE AND NOVEL SAMPLE TYPES AND SAMPLING PROTOCOLS TO IDENTIFY EMERGING DISEASE EARLIER. INVESTIGATE NEWLY IDENTIFIED AGENTS ASSOCIATED WITH DISEASE TO UNDERSTAND THE CLINICAL RELEVANCE AND EPIDEMIOLOGY OF NOVEL VIRUSES AND BACTERIA. VETERINARY DIAGNOSTIC LABS CONTINUE TO IDENTIFY THESE VIRUSES AND UNDERSTANDING ASSOCIATIONS WITH CLINICAL DISEASE SYNDROMES IS CRITICAL. BETTER UNDERSTANDING OF THE EPIDEMIOLOGY AND PATHOGENICITY OF THE AGENTS ARE IMPORTANT TO IDENTIFYING IF THEY HAVE A ROLE IN CLINICAL DISEASE. 115793 81431 IDENTIFY HIGH RISK EVENTS LIKELY TO BE RESPONSIBLE FOR INTRODUCING EMERGING DISEASES ONTO FARMS THROUGH OUTBREAK INVESTIGATIONS. REFINE AND ENHANCE THE RAPID RESPONSE PROGRAM, WHICH HELPS PRODUCERS AND VETERINARIANS RESPOND TO AND MANAGE NEWLY EMERGING DISEASES. ENHANCE RESPONSIVENESS AND EFFICIENCY OF OUTBREAK INVESTIGATIONS TO UNDERSTAND EPIDEMIOLOGICALLY DISTINCT INCIDENTS OF ENDEMIC DISEASE OUTBREAKS. AUTOMATE AND STREAMLINE THE RAPID RESPONSE INVESTIGATION PROCESS. IDENTIFY EARLY WARNINGS OF DISEASE EVENTS FOR RAPID RESPONSE AND QUICKLY RESEARCH PATHOGENS CAUSING EMERGING DISEASE OUTBREAKS. ASSESS EFFECTIVENESS OF SANITATION AND DECONTAMINATION PROTOCOLS. IMPROVE THE ABILITY TO INVESTIGATE DISEASE OUTBREAKS THROUGH FORENSIC DIAGNOSTIC TOOLS TO ENHANCE EMERGING DISEASE DISCOVERY. QUICKLY RESEARCH PATHOGENS CAUSING EMERGING DISEASE OUTBREAKS. ENSURE COMMUNICATIONS PATHWAY WILL FACILITATE RAPID RESPONSE TO AN EMERGING DISEASE, AND ENSURE RESOURCES ARE AVAILABLE TO HELP DETECT, PREPARE, AND RESPOND TO EMERGING DISEASES ON THE FARM. 115793 81431 2805148 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7 0 1 2 0 0 0 0 0 0 0 0 0 0 0 X 9 9 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 0 0 1 0 0 X DR MEGAN NIEDERWERDER ASSOCIATE D 7854528270 1310 WESTLOOP PLACE A 270 MANHATTAN KS 66502 X DARYL OLSEN DIRECTOR & PRESIDENT 3.00 X X 0 0 0 HOWARD HILL DIRECTOR & VICE PRESIDENT 3.00 X X 0 0 0 MATTHEW TURNER DIRECTOR 2.00 X 0 0 0 MARK SCHWARTZ DIRECTOR & VICE PRESIDENT 3.00 X X 0 0 0 GENE NOEM DIRECTOR 2.00 X 0 0 0 JEREMY PITTMAN DIRECTOR 2.00 X 0 0 0 RUSS NUGENT DIRECTOR & PRESIDENT 3.00 X X 0 0 0 KENT BANG DIRECTOR, SECRETARY & TREA 3.00 X X 0 0 0 PAUL RUEN DIRECTOR 2.00 X 0 0 0 JOE DYKHUIS DIRECTOR 2.00 X 0 0 0 PETE THOMAS DIRECTOR 2.00 X 0 0 0 DR PAUL SUNDBERG EXECUTIVE DIRECTOR 40.00 X 310826 0 9351 DR MEGAN NIEDERWERDER ASSOCIATE DIRECTOR 40.00 X 237695 0 9319 548521 0 18670 2 0 1 0 0 2887030 2887030 272400 272400 3159430 0 0 272400 1946090 1946090 548521 521095 27426 91199 86639 4560 29652 28169 1483 28826 28826 3593 3593 69983 69983 7914 7914 CONTRACTED SERVICES 91040 81040 10000 COMMUNICATIONS 64218 64218 SUBSCRIPTIONS, MEMBERSH 8830 8830 MISCELLANEOUS 4587 4587 5434 5434 2899887 2805148 94739 0 2224760 444933 4483471 6110258 2133 2577 6710364 6557768 1272263 1663245 1272263 1663245 X 0 0 0 0 5438101 4894523 5438101 4894523 6710364 6557768 X 259543 -15158 -787963 X 0 0 0 X 1165442 602754 200 4432607 2879720 9080723 1165442 602754 200 4432607 2879720 9080723 9080723 150123 118858 45514 -26943 272400 559952 9640675 0.94190 0.96270 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 PIPESTONE APPLIED RESEARCH 1300 SO HWY 75 PIPESTONE MN 56164 352491093 61100 0 FMV RESEARCH IOWA STATE UNIVERSITY 1750 BEARDSHEAR HALL AMES IA 50011 426004224 115 686743 0 FMV RESEARCH NORTH CAROLINA STATE UNIVERSITY 120 BROUGHTON DRIVE SUITE 123 RALEIGH NC 27695 566000756 GOVERNMENTAL 131671 0 FMV RESEARCH UNIVERSITY OF MINNESOTA 2221 UNIVERSITY AVE SE MINNEAPOLIS MN 55414 416007513 GOVERNMENTAL 469455 0 FMV RESEARCH UNIVERSITY OF MISSOURI 230 JESSE HALL COLUMBIA MO 65211 436003859 115 GOVERNMENTAL 179933 0 FMV RESEARCH TEXAS TECH UNIVERSITY 2500 BROADWAY W LUBBOCK TX 79409 756002622 115 GOVERNMENTAL 119018 0 FMV RESEARCH UNIVERSITY OF MONTREAL 2900 BD EDOUARD-MONTPETIT MONTREAL QUEBEC CA GOVERNMENTAL 125930 0 FMV RESEARCH CARTHAGE INNOVATIVE SWINE SOLUTIONS 303 N 2ND ST CARTHAGE IL 62321 75850 0 FMV RESEARCH SWINE VET CENTER PA 1608 SOUTH MINNESOTA AVE ST PETER MN 56082 411682225 41115 0 FMV RESEARCH LOWE CONSULTING 2193 HOMER LAKE ROAD ST JOSEPH IL 61873 453551042 26400 0 FMV RESEARCH TALENT METRICS CONSULTING 7611 LAKE HANCOCK BLVD WINTER GARDEAN FL 34787 834710622 28875 0 FMV RESEARCH 6 5 PART I, LINE 2: PROGRESS REPORTS ARE REQUIRED, ALONG WITH MAINTAINING RECORDS ITEMIZING THE RECEIPT AND EXPENDITURE OF ALL FUNDS, WITH SUCH RECORDS BEING AVAILABLE UPON REQUEST BY THE ORGANIZATION, AND A FINAL REPORT MUST BE PREPARED SUITABLE FOR PUBLIC RELEASE. X X 0 0 0 0 0 0 0 0 0 DR PAUL SUNDBERG EXECUTIVE DIRECTOR 288906 0 21920 0 0 0 9351 0 0 0 320177 0 0 0 DR MEGAN NIEDERWERDER ASSOCIATE DIRECTOR 223162 0 14533 0 0 0 9319 0 0 0 247014 0 0 0 FORM 990, PART VI, SECTION A, LINE 7A EACH OF THREE SEPARATE ORGANIZATIONS (A GOVERNMENTAL ENTITY AND TWO NONPROFIT CORPORATIONS) HAS THE RIGHT UNDER THE BYLAWS TO APPOINT TWO INDIVIDUALS TO THE BOARD OF DIRECTORS, FOR A TOTAL OF SIX APPOINTED DIRECTORS. THEN, THOSE SIX INDIVIDUAL DIRECTORS ELECT THE REMAINING THREE DIRECTORS (FOR A TOTAL OF NINE INDIVIDUALS ON THE BOARD OF DIRECTORS). FORM 990, PART VI, SECTION B, LINE 11B THE RETURN PREPARER E-MAILED A DRAFT TO THE EXECUTIVE DIRECTOR FOR CIRCULATION TO THE OFFICERS FOR REVIEW. ANY QUESTIONS, ISSUES, AND CHANGES RAISED BY THE OFFICER OR EXECUTIVE DIRECTOR ARE RESOLVED BEFORE FILING THE 990. FORM 990, PART VI, SECTION B, LINE 12C CONSISTENT WITH THE ADOPTED WRITTEN CONFLICT OF INTEREST POLICY, EACH "RESPONSIBLE PERSON" REVIEWS THE POLICY AND COMPLETES THE DISCLOSURE FORM ANNUALLY, PLUS, BEFORE THE ORGANIZATION ENTERS INTO A TRANSACTION REQUIRING APPROVAL BY THE BOARD OF DIRECTORS, THE POLICY IS CONSIDERED AND THE BOARD DETERMINES TO WHAT EXTENT A CONFLICT OF INTEREST EXISTS AND THE POLICY IS FOLLOWED ACCORDINGLY. FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS OBTAINED AND REVIEWED VARIOUS INDEPENDENT, MARKET DATA OF COMPENSATION ARRANGEMENTS FOR EXECUTIVE DIRECTORS OF TAX-EXEMPT ORGANIZATIONS AND DISCUSSED AND DELIBERATED THE SAME AND ULTIMATELY DECIDED ON DR. NIEDERWERDER'S COMPENSATION FOR 2023. FORM 990, PART VI, SECTION C, LINE 19 NONE OF THESE DOCUMENTS WERE MADE AVAILABLE TO THE PUBLIC AS NO REQUEST WAS MADE BY THE PUBLIC. IF SUCH A REQUEST IS MADE, THE ORGANIZATION WILL COMPLY TO THE EXTENT REQUIRED BY LAW. FORM 990, PART XI, LINE 9: BOOK/TAX DIFFERENCE TO LIABILITIES -787,963.